Circulating lncRNA levels too low to serve as biomarkers

Long non-coding RNAs (lncRNA) are a new class of regulatory molecules with diverse cellular functions. Recent reports have suggested that extracellular lncRNAs are detectable in human plasma and may serve as biomarkers. Here, researchers at the Ottawa Hospital Research Institute sought to investigate circulating lncRNAs as potential biomarkers for pulmonary arterial hypertension (PAH). Eighty-four lncRNAs, representing some of the most abundant and functionally relevant candidates identified in cellular studies, were assessed via RT-qPCR in plasma from PAH and healthy subjects. However, despite preamplification, the majority of lncRNAs were surprisingly undetectable or sporadically detectable, and showed no differential changes. Systematic characterization of plasma/RNA quality and technical performance via internal and external controls revealed no evidence of RNA degradation or RT-qPCR inhibition, and most lncRNAs were robustly detectable in pulmonary tissue. In plasma, lncRNA levels were the lowest among several different RNA species examined, and this was generalizable to other chronic and acute vascular conditions including coronary artery disease, acute coronary syndrome, and septic shock. In addition, two of three previously reported circulating lncRNA biomarker candidates were not detectable in any of the plasma samples. This study reveals new insight on the relative levels of lncRNAs in circulation, which has important implications for their potential development as biomarkers.

Low and sporadic lncRNA detection in PAH and healthy subject plasma


Heatmap showing color coded relative lncRNA plasma levels expressed fold to the PCR detection limit (Cq = 35; Relative Level = 1) after log transformation. Each column represents a unique subject and each row represents a different lncRNA, which have been arranged arbitrarily in ascending (mean) abundance. LncRNAs that were not detected in any subjects are listed next to the heatmap. Right graph shows relative lncRNA levels of individual subjects (circles).

Schlosser K, Hanson J, Villeneuve PJ, Dimitroulakos J, McIntyre L, Pilote L, Stewart DJ. (2016) Assessment of Circulating LncRNAs Under Physiologic and Pathologic Conditions in Humans Reveals Potential Limitations as Biomarkers. Sci Rep 6:36596. [article]

Leave a Reply

Your email address will not be published. Required fields are marked *